he new FDA warning about using erythropoietin stimulating agents to treat anemia in patients with chronic kidney disease.
Submit your own story to this site: darkejournal@gmail.com
he new FDA warning about using erythropoietin stimulating agents to treat anemia in patients with chronic kidney disease.
Sunday, October 23, 2011 Labels: anemia, Aranesp, darbepoetin, epoetin, Epogen, erythropoietin, Procrit
0 comment(s):
Post a Comment